These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2511340)

  • 1. Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder.
    Pan JS; Slocum HK; Rustum YM; Greco WR; Gaeta JF; Huben RP
    J Urol; 1989 Dec; 142(6):1589-93. PubMed ID: 2511340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
    Wang SH
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
    Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
    J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer.
    Br J Urol; 1994 Jun; 73(6):632-8. PubMed ID: 8032829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of bladder tumor implantation. Intravesical and systemic chemotherapy.
    Soloway MS; Martino C
    Urology; 1976 Jan; 7(1):29-34. PubMed ID: 813346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial.
    Zincke H; Utz DC; Taylor WF; Myers RP; Leary FJ
    J Urol; 1983 Mar; 129(3):505-9. PubMed ID: 6403716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results].
    Durán R; Reina GR; Hontoria JM; Merino C; Olivier C; Carballido J
    Actas Urol Esp; 1989; 13(1):19-23. PubMed ID: 2496583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
    Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of immediate instillation combined with regular instillations of pirarubicin for Ta and T1 transitional cell bladder cancer after transurethral resection: a prospective, randomized, multicenter study.
    Li NC; Ye ZQ; Na YQ;
    Chin Med J (Engl); 2013; 126(15):2805-9. PubMed ID: 23924446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic adenoma in patients with transitional cell carcinoma of the bladder receiving intravesical thiotepa.
    Wood DP; Streem SB; Levin HS
    J Urol; 1988 Jan; 139(1):130-1. PubMed ID: 3121867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucralfate inhibition of tumor cell implantation in the murine urinary bladder.
    Van Every MJ; Sago AL; Ehler WJ; Novicki DE
    J Urol; 1988 Jul; 140(1):188-90. PubMed ID: 3379686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
    Toulouse J; Bouffier B; Etievent JP; Bittard M
    J Urol (Paris); 1983; 89(2):85-9. PubMed ID: 6408192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nitrofurantoin on bladder tumor cell lines: in vitro growth and implantation in the cauterized mouse bladder.
    Bulbul MA; Chin JL; Huben RP; Englander LS; Pontes JE
    J Urol; 1985 Dec; 134(6):1231-5. PubMed ID: 4057424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.
    Sindhwani P; Hampton JA; Baig MM; Keck R; Selman SH
    J Urol; 2001 Oct; 166(4):1498-501. PubMed ID: 11547120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
    Burnand KG; Boyd PJ; Mayo ME; Shuttleworth KE; Lloyd-Davies RW
    Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
    J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.